Keynote Panel: The benefits of AI within drug discovery

---

---

Co-Founder & Chief Business Officer

Joining panel chair Dr Ivan Griffin, our Co-Founder & Chief Business Officer, and Dr James Malone, Chief Technology Officer, for the compelling BioTechX Europe Keynote Panel 2024 are:

• AstraZeneca's Head of AI Strategy & Innovation, Hebe Middlemiss
• Merck Group's Director & Head of AI & New Technologies, Daniel Kuhn
• Novartis' VP & Global Head of AI & Computational Sciences, Bulent Kiziltan, PhD
• QIAGEN's Director of Product Management, Digital Insights Base, Venkatesh Moktali, PhD

---

Back to blog post and videos